Clinical Trial Update: Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating temozolomide and irinotecan in MGMT-silenced colorectal cancer after adjuvant chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN